Supplementary Data 1 from Tumor-Infiltrating Normal B Cells Revealed by Immunoglobulin Repertoire Clonotype Analysis Are Highly Prognostic and Crucial for Antitumor Immune Responses in DLBCL
Publication
, Other
Xu-Monette, ZY; Li, Y; Snyder, T; Yu, T; Lu, T; Tzankov, A; Visco, C; Bhagat, G; Qian, W; Dybkaer, K; Chiu, A; Tam, W; Zu, Y; Hsi, ED ...
December 1, 2023
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Xu-Monette, Z. Y., Li, Y., Snyder, T., Yu, T., Lu, T., Tzankov, A., … Young, K. H. (2023). Supplementary Data 1 from Tumor-Infiltrating Normal B Cells Revealed by Immunoglobulin Repertoire Clonotype Analysis Are Highly Prognostic and Crucial for Antitumor Immune Responses in DLBCL. https://doi.org/10.1158/1078-0432.24710901
Xu-Monette, Zijun Y., Yong Li, Thomas Snyder, Tiantian Yu, Tingxun Lu, Alexandar Tzankov, Carlo Visco, et al. “Supplementary Data 1 from Tumor-Infiltrating Normal B Cells Revealed by Immunoglobulin Repertoire Clonotype Analysis Are Highly Prognostic and Crucial for Antitumor Immune Responses in DLBCL,” December 1, 2023. https://doi.org/10.1158/1078-0432.24710901.
Xu-Monette ZY, Li Y, Snyder T, Yu T, Lu T, Tzankov A, et al. Supplementary Data 1 from Tumor-Infiltrating Normal B Cells Revealed by Immunoglobulin Repertoire Clonotype Analysis Are Highly Prognostic and Crucial for Antitumor Immune Responses in DLBCL. 2023.
Xu-Monette, Zijun Y., et al. Supplementary Data 1 from Tumor-Infiltrating Normal B Cells Revealed by Immunoglobulin Repertoire Clonotype Analysis Are Highly Prognostic and Crucial for Antitumor Immune Responses in DLBCL. 1 Dec. 2023. Crossref, doi:10.1158/1078-0432.24710901.
Xu-Monette ZY, Li Y, Snyder T, Yu T, Lu T, Tzankov A, Visco C, Bhagat G, Qian W, Dybkaer K, Chiu A, Tam W, Zu Y, Hsi ED, Hagemeister FB, Wang Y, Go H, Ponzoni M, Ferreri AJM, Møller MB, Parsons BM, Fan X, van Krieken JH, Piris MA, Winter JN, Au Q, Kirsch I, Zhang M, Shaughnessy J, Xu B, Young KH. Supplementary Data 1 from Tumor-Infiltrating Normal B Cells Revealed by Immunoglobulin Repertoire Clonotype Analysis Are Highly Prognostic and Crucial for Antitumor Immune Responses in DLBCL. 2023.